Evaluation of pemetrexed (Alimta, LY231514) as second-line...

Evaluation of pemetrexed (Alimta, LY231514) as second-line chemotherapy in persistent or recurrent carcinoma of the cervix: the CERVIX 1 study of the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group

Lorusso, D., Ferrandina, G., Pignata, S., Ludovisi, M., Vigano, R., Scalone, S., Scollo, P., Breda, E., Pietragalla, A., Scambia, G.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
21
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdp266
Date:
January, 2010
File:
PDF, 80 KB
english, 2010
Conversion to is in progress
Conversion to is failed